vs
Side-by-side financial comparison of IRIDEX CORP (IRIX) and Osisko Development Corp. (ODV). Click either name above to swap in a different company.
IRIDEX CORP is the larger business by last-quarter revenue ($14.7M vs $10.4M, roughly 1.4× Osisko Development Corp.).
IRIDEX Corporation is a global medical technology company that designs, manufactures and distributes advanced laser-based medical devices, primarily serving the ophthalmology and aesthetic medicine sectors. It supplies products to healthcare providers, clinics and medical facilities across North America, Europe, Asia Pacific and other regions, delivering minimally invasive solutions for eye disease treatment and cosmetic procedures.
Osisko Development Corp. is a Canada-based mining exploration and development firm focused on high-grade gold and precious metal assets. It holds North American mineral projects, advancing them through exploration, feasibility study, and pre-production phases while adhering to sustainable mining standards.
IRIX vs ODV — Head-to-Head
Income Statement — Q4 FY2025 vs Q3 FY2024
| Metric | | |
|---|---|---|
| Revenue | $14.7M | $10.4M |
| Net Profit | — | — |
| Gross Margin | 37.2% | 3.2% |
| Operating Margin | — | -149.3% |
| Net Margin | — | — |
| Revenue YoY | -69.7% | — |
| Net Profit YoY | — | — |
| EPS (diluted) | — | — |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $14.7M | — | ||
| Q3 25 | $12.5M | — | ||
| Q2 25 | $13.6M | — | ||
| Q1 25 | $11.9M | — | ||
| Q4 24 | $12.7M | — | ||
| Q3 24 | $11.6M | $10.4M | ||
| Q2 24 | $12.6M | $10.8M | ||
| Q1 24 | $11.8M | — |
| Q4 25 | — | — | ||
| Q3 25 | $-1.6M | — | ||
| Q2 25 | $-994.0K | — | ||
| Q1 25 | $-1.7M | — | ||
| Q4 24 | $-834.0K | — | ||
| Q3 24 | $-1.9M | — | ||
| Q2 24 | $-2.7M | — | ||
| Q1 24 | $-3.5M | — |
| Q4 25 | 37.2% | — | ||
| Q3 25 | 32.1% | — | ||
| Q2 25 | 34.5% | — | ||
| Q1 25 | 42.5% | — | ||
| Q4 24 | 44.0% | — | ||
| Q3 24 | 37.3% | 3.2% | ||
| Q2 24 | 40.7% | — | ||
| Q1 24 | 37.9% | — |
| Q4 25 | — | — | ||
| Q3 25 | -11.3% | — | ||
| Q2 25 | -6.9% | — | ||
| Q1 25 | -1.7% | — | ||
| Q4 24 | -3.9% | — | ||
| Q3 24 | -16.1% | -149.3% | ||
| Q2 24 | -20.9% | -124.0% | ||
| Q1 24 | -28.0% | — |
| Q4 25 | — | — | ||
| Q3 25 | -12.6% | — | ||
| Q2 25 | -7.3% | — | ||
| Q1 25 | -14.2% | — | ||
| Q4 24 | -6.6% | — | ||
| Q3 24 | -16.7% | — | ||
| Q2 24 | -21.2% | — | ||
| Q1 24 | -29.5% | — |
| Q4 25 | — | — | ||
| Q3 25 | $-0.09 | — | ||
| Q2 25 | $-0.06 | — | ||
| Q1 25 | $-0.10 | — | ||
| Q4 24 | $-0.05 | — | ||
| Q3 24 | $-0.12 | — | ||
| Q2 24 | $-0.16 | — | ||
| Q1 24 | $-0.21 | — |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $6.0M | — |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | — | — |
| Total Assets | $29.2M | — |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $6.0M | — | ||
| Q3 25 | $5.6M | — | ||
| Q2 25 | $6.8M | — | ||
| Q1 25 | $7.2M | — | ||
| Q4 24 | $2.4M | — | ||
| Q3 24 | $3.9M | — | ||
| Q2 24 | $4.1M | — | ||
| Q1 24 | $5.4M | — |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | $1.0M | — | ||
| Q3 24 | $1.4M | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | — | — | ||
| Q3 25 | $4.7M | — | ||
| Q2 25 | $6.1M | — | ||
| Q1 25 | $852.0K | — | ||
| Q4 24 | $2.1M | — | ||
| Q3 24 | $2.6M | — | ||
| Q2 24 | $4.2M | — | ||
| Q1 24 | $6.5M | — |
| Q4 25 | $29.2M | — | ||
| Q3 25 | $28.4M | — | ||
| Q2 25 | $31.6M | — | ||
| Q1 25 | $34.2M | — | ||
| Q4 24 | $29.1M | — | ||
| Q3 24 | $30.2M | — | ||
| Q2 24 | $31.2M | — | ||
| Q1 24 | $34.1M | — |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 0.48× | — | ||
| Q3 24 | 0.53× | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
